Page last updated: 2024-08-24

dexmedetomidine and Primary Graft Dysfunction

dexmedetomidine has been researched along with Primary Graft Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cui, C; Jiao, Y; Ma, D; Masters, J; Ni, C; Qi, B; Yang, L; Yang, Y; Yin, S; Yu, W; Zhu, L	1

Trials

1 trial(s) available for dexmedetomidine and Primary Graft Dysfunction

Article	Year
Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation. Trials, 2020, Jun-26, Volume: 21, Issue:1 Topics: Adrenergic alpha-2 Receptor Agonists; Clinical Trials, Phase I as Topic; Dexmedetomidine; Humans; Kidney; Liver; Liver Transplantation; Perioperative Period; Primary Graft Dysfunction; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome	2020

Article

Year

Study design of the DAS-OLT trial: a randomized controlled trial to evaluate the impact of dexmedetomidine on early allograft dysfunction following liver transplantation.

Trials, 2020, Jun-26, Volume: 21, Issue:1

Topics: Adrenergic alpha-2 Receptor Agonists; Clinical Trials, Phase I as Topic; Dexmedetomidine; Humans; Kidney; Liver; Liver Transplantation; Perioperative Period; Primary Graft Dysfunction; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome

2020